biostudies-literatureKhodyakov DNIA NIH HHSNational Institutes of HealthNational Institute on Aging586-591https://www.ebi.ac.uk/biostudies/studies/S-EPMC5370573biostudies-literatureUnknown65(3)<h4>Objectives</h4>To develop a set of prescribing indicators measurable with available data from electronic nursing home (NH) databases by adapting the European-based 2014 Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tools to Alert Doctors to Right Treatment (START) criteria of potentially inappropriate and underused medications for the U.S.<h4>Setting</h4><h4>Design</h4>A two-stage expert panel process. In the first stage, the investigator team reviewed 114 criteria for compatibility and measurability. In the second stage, an online modified e-Delphi (OMD) panel was convened to rate the validity of criteria, and two webinars were held to identify criteria with highest relevance to U.S. NHs.<h4>Participants</h4>Seventeen experts with recognized reputations in NH caJournal of the American Geriatrics SocietyScreening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting.PMC5370573R01AG0463R01 AG046341Briesacher BKhodyakov DChing DOlivieri-Mui BLBouwmeester CPatel MOchoa AZarowitz BJfalseScreening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting.<h4>Objectives</h4>To develop a set of prescribing indicators measurable with available data from electronic nursing home (NH) databases by adapting the European-based 2014 Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tools to Alert Doctors to Right Treatment (START) criteria of potentially inappropriate and underused medications for the U.S.<h4>Setting</h4><h4>Design</h4>A two-stage expert panel process. In the first stage, the investigator team reviewed 114 criteria for compatibility and measurability. In the second stage, an online modified e-Delphi (OMD) panel was convened to rate the validity of criteria, and two webinars were held to identify criteria with highest relevance to U.S. NHs.<h4>Participants</h4>Seventeen experts with recognized reputations in NH ca2017-01-01T00:00:00Z2017 Mar2025-04-04T13:14:18.913Z2019-03-26T23:04:14ZS-EPMC53705732800859910.1111/jgs.14689